Biosynthetic Pathways of the Endocannabinoid Anandamide
✍ Scribed by Yasuo Okamoto; Jun Wang; Jun Morishita; Natsuo Ueda
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 163 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1612-1872
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Endocannabinoids are a family of endogenous signaling molecules that modulate neuronal excitability in the central nervous system (CNS) by interacting with cannabinoid (CB) receptors. In spite of the evidence that astroglial cells also possess CB receptors, there is no information on th
## Abstract Endocannabinoids are now emerging as suppressors of key cell‐signaling pathways involved in cancer cell growth, invasion, and metastasis. We have previously observed that the metabolically stable anandamide analog, 2‐methyl‐2′‐F‐anandamide (Met‐F‐AEA) can inhibit the growth of thyroid c
## Abstract Anandamide (__N‐__arachidonylethanolamine) is an endogenous cannabinoid receptor ligand that has been implicated in various physiological and pathophysiological functions. In the present study, a liquid–liquid extraction‐based reversed‐phase HPLC method with fluorometric detection was v